Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Retained Earnings (2016 - 2025)

AC Immune (ACIU) has disclosed Retained Earnings for 9 consecutive years, with -$420.4 million as the latest value for Q4 2024.

  • On a quarterly basis, Retained Earnings fell 17.92% to -$420.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$420.4 million, a 17.92% decrease, with the full-year FY2024 number at -$420.4 million, down 19.4% from a year prior.
  • Retained Earnings was -$420.4 million for Q4 2024 at AC Immune, down from -$356.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$147.0 million in Q4 2020 to a low of -$420.4 million in Q4 2024.
  • A 5-year average of -$283.1 million and a median of -$274.1 million in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: crashed 92.59% in 2020, then fell 17.92% in 2024.
  • AC Immune's Retained Earnings stood at -$147.0 million in 2020, then tumbled by 48.29% to -$217.9 million in 2021, then fell by 25.76% to -$274.1 million in 2022, then tumbled by 30.07% to -$356.5 million in 2023, then dropped by 17.92% to -$420.4 million in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Retained Earnings are -$420.4 million (Q4 2024), -$356.5 million (Q4 2023), and -$274.1 million (Q4 2022).